{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:34:10Z","timestamp":1780497250025,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40272-026-00740-x","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:42:21Z","timestamp":1770478941000},"page":"197-207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of \u03b2-Blockers on the Risk of Low-Birth-Weight Infants in Women with Long QT Syndrome or Marfan Syndrome: A Single-Center Retrospective Study from 2008 to 2022 in a Tertiary Care Center"],"prefix":"10.1007","volume":"28","author":[{"given":"M\u00e9lissa","family":"Gr\u00e9gori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurianne","family":"Le Gloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Goronflot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Gourraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Misbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Winer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8077-0288","authenticated-orcid":false,"given":"Vincent","family":"Dochez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"issue":"34","key":"740_CR1","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","volume":"39","author":"V Regitz-Zagrosek","year":"2018","unstructured":"Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165\u2013241. https:\/\/doi.org\/10.1093\/eurheartj\/ehy340.","journal-title":"Eur Heart J"},{"issue":"10","key":"740_CR2","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/s0002-9149(97)00163-x","volume":"79","author":"GY Lip","year":"1997","unstructured":"Lip GY, Beevers M, Churchill D, Shaffer LM, Beevers DG. Effect of atenolol on birth weight. Am J Cardiol. 1997;79(10):1436\u20138. https:\/\/doi.org\/10.1016\/s0002-9149(97)00163-x.","journal-title":"Am J Cardiol"},{"issue":"6752","key":"740_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/bmj.301.6752.587","volume":"301","author":"L Butters","year":"1990","unstructured":"Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ. 1990;301(6752):587\u20139. https:\/\/doi.org\/10.1136\/bmj.301.6752.587.","journal-title":"BMJ"},{"issue":"8","key":"740_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jgyn.2013.09.013","volume":"42","author":"A Gaudineau","year":"2013","unstructured":"Gaudineau A. Prevalence, risk factors, maternal and fetal morbidity and mortality of intrauterine growth restriction and small-for-gestational age. J Gynecol Obstet Biol Reprod (Paris). 2013;42(8):895\u2013910. https:\/\/doi.org\/10.1016\/j.jgyn.2013.09.013.","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"9","key":"740_CR5","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1111\/1471-0528.17814","volume":"131","author":"RK Morris","year":"2024","unstructured":"Morris RK, Johnstone E, Lees C, Morton V, Smith G, Royal College of Obstetricians and Gynaecologists. Investigation and care of a small-for-gestational-age fetus and a growth restricted fetus (Green-top guideline No. 31). BJOG Int J Obstet Gynaecol. 2024;131(9):e31\u201380. https:\/\/doi.org\/10.1111\/1471-0528.17814.","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"2","key":"740_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/HJH.0000000000002256","volume":"38","author":"A Kayser","year":"2020","unstructured":"Kayser A, Beck E, Hoeltzenbein M, et al. Neonatal effects of intrauterine metoprolol\/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups. J Hypertens. 2020;38(2):354\u201361. https:\/\/doi.org\/10.1097\/HJH.0000000000002256.","journal-title":"J Hypertens"},{"issue":"10","key":"740_CR7","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1097\/HJH.0000000000001818","volume":"36","author":"M Hoeltzenbein","year":"2018","unstructured":"Hoeltzenbein M, Fietz AK, Kayser A, Zinke S, Meister R, Weber-Schoendorfer C, et al. Pregnancy outcome after first trimester exposure to bisoprolol: an observational cohort study. J Hypertens. 2018;36(10):2109\u201317. https:\/\/doi.org\/10.1097\/HJH.0000000000001818.","journal-title":"J Hypertens"},{"issue":"5","key":"740_CR8","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/1471-0528.12522","volume":"121","author":"AS Ersb\u00f8ll","year":"2014","unstructured":"Ersb\u00f8ll AS, Hedegaard M, S\u00f8ndergaard L, Ersb\u00f8ll M, Johansen M. Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction. BJOG Int J Obstet Gynaecol. 2014;121(5):618\u201326. https:\/\/doi.org\/10.1111\/1471-0528.12522.","journal-title":"BJOG"},{"issue":"10","key":"740_CR9","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1253\/circj.CJ-15-0617","volume":"80","author":"K Tanaka","year":"2016","unstructured":"Tanaka K, Tanaka H, Kamiya C, et al. Beta-blockers and fetal growth restriction in pregnant women with cardiovascular disease. Circ J. 2016;80(10):2221\u20136. https:\/\/doi.org\/10.1253\/circj.CJ-15-0617.","journal-title":"Circ J"},{"issue":"4","key":"740_CR10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1253\/circj.CJ-22-0647","volume":"87","author":"K Kubota","year":"2023","unstructured":"Kubota K, Inai K, Shimada E, Shinohara T. \u03b1\/\u03b2- and \u03b2-blocker exposure in pregnancy and the risk of neonatal hypoglycemia and small for gestational age. Circ J. 2023;87(4):569\u201377. https:\/\/doi.org\/10.1253\/circj.CJ-22-0647.","journal-title":"Circ J"},{"issue":"4","key":"740_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-001185","volume":"2","author":"K Meidahl Petersen","year":"2012","unstructured":"Meidahl Petersen K, Jimenez-Solem E, Andersen JT, et al. \u03b2-blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study. BMJ Open. 2012;2(4):e001185. https:\/\/doi.org\/10.1136\/bmjopen-2012-001185.","journal-title":"BMJ Open"},{"issue":"4","key":"740_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jacc.2018.10.075","volume":"73","author":"DG Halpern","year":"2019","unstructured":"Halpern DG, Weinberg CR, Pinnelas R, Mehta-Lee S, Economy KE, Valente AM. Use of medication for cardiovascular\u00a0disease\u00a0during pregnancy: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(4):457\u201376. https:\/\/doi.org\/10.1016\/j.jacc.2018.10.075.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"740_CR13","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/AOG.0b013e31820cab69","volume":"117","author":"E Gelson","year":"2011","unstructured":"Gelson E, Curry R, Gatzoulis MA, Swan L, Lupton M, Steer P, et al. Effect of maternal heart disease on fetal growth. Obstet Gynecol. 2011;117(4):886\u201391. https:\/\/doi.org\/10.1097\/AOG.0b013e31820cab69.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"740_CR14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1136\/heartjnl-2018-313551","volume":"105","author":"M Cauldwell","year":"2019","unstructured":"Cauldwell M, Steer P, Sterrenburg M, Wallace S, Malin G, Ulivi G, et al. Birth weight in pregnancies complicated by maternal heart disease. Heart. 2019;105(5):391\u20138. https:\/\/doi.org\/10.1136\/heartjnl-2018-313551.","journal-title":"Heart"},{"key":"740_CR15","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1136\/hrt.2006.095240","volume":"92","author":"S Thorne","year":"2006","unstructured":"Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart. 2006;92:1520\u20135.","journal-title":"Heart"},{"key":"740_CR16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0368-2315(10)70024-7","volume":"39","author":"N Winer","year":"2010","unstructured":"COLL\u00c8GE NATIONAL DES GYN\u00c9COLOGUES ET OBST\u00c9TRICIENS FRAN\u00c7AIS, Winer N, Caroit Y, Sbelin JE, Hilippe HJP. Mises \u00e0 jour en Gyn\u00e9cologie et Obst\u00e9trique Publi\u00e9 le 10 d\u00e9cembre 2010. J Gynecol Obstet Biol Reprod. 2010;39:S1\u2013342.","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"740_CR17","doi-asserted-by":"publisher","first-page":"102352","DOI":"10.1016\/j.jogoh.2022.102352","volume":"51","author":"Y Dabi","year":"2022","unstructured":"Dabi Y, Thubert T, Fuchs F, Barjat T, Belaisch-Allart J, Ceccaldi PF, et al. How is functioning the Ethical Review Board \u00ab\u202fComit\u00e9 d\u2019Ethique pour la Recherche en Obst\u00e9trique et Gyn\u00e9cologie\u202f\u00bb (CEROG)? J Gynecol Obstet Hum Reprod. 2022;51:102352. https:\/\/doi.org\/10.1016\/j.jogoh.2022.102352.","journal-title":"J Gynecol Obstet Hum Reprod."},{"issue":"21","key":"740_CR18","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1016\/j.jacc.2020.03.068","volume":"75","author":"J Grewal","year":"2020","unstructured":"Grewal J, Siu SC, Lee T, D\u2019Souza R, Dvir M, Singer J, et al. Impact of beta-blockers on birth weight in a high-risk cohort of pregnant women with CVD. J Am Coll Cardiol. 2020;75(21):2751\u20132. https:\/\/doi.org\/10.1016\/j.jacc.2020.03.068.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"740_CR19","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/jch.13397","volume":"20","author":"L Duan","year":"2018","unstructured":"Duan L, Ng A, Chen W, Spencer HT, Lee MS. Beta-blocker subtypes and risk of low birth weight in newborns. J Clin Hypertens (Greenwich). 2018;20(11):1603\u20139. https:\/\/doi.org\/10.1111\/jch.13397.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"7","key":"740_CR20","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/aogs.14363","volume":"101","author":"IK S\u00f8rbye","year":"2022","unstructured":"S\u00f8rbye IK, Haualand R, Wiull H, Letting AS, Langesaeter E, Estensen ME. Maternal beta-blocker dose and risk of small-for gestational-age in women with heart disease. Acta Obstet Gynecol Scand. 2022;101(7):794\u2013802. https:\/\/doi.org\/10.1111\/aogs.14363.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"8","key":"740_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017834","volume":"10","author":"I Hardee","year":"2021","unstructured":"Hardee I, Wright L, McCracken C, Lawson E, Oster ME. Maternal and neonatal outcomes of pregnancies in women with congenital heart disease: a meta-analysis. J Am Heart Assoc. 2021;10(8):e017834. https:\/\/doi.org\/10.1161\/JAHA.120.017834.","journal-title":"J Am Heart Assoc"},{"issue":"24","key":"740_CR22","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1016\/j.jacc.2007.03.027","volume":"49","author":"W Drenthen","year":"2007","unstructured":"Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol. 2007;49(24):2303\u201311. https:\/\/doi.org\/10.1016\/j.jacc.2007.03.027.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"740_CR23","doi-asserted-by":"publisher","first-page":"263.e1","DOI":"10.1016\/j.ajog.2019.09.004","volume":"222","author":"BF Cuneo","year":"2020","unstructured":"Cuneo BF, Kaizer AM, Clur SA, et al. Mothers with long QT syndrome are at increased risk for fetal death: findings from a multicenter international study. Am J Obstet Gynecol. 2020;222(3):263.e1-263.e11. https:\/\/doi.org\/10.1016\/j.ajog.2019.09.004.","journal-title":"Am J Obstet Gynecol"},{"key":"740_CR24","unstructured":"Centre de r\u00e9f\u00e9rence Syndrome de Marfan et apparent\u00e9s. Protocole National de Diagnostic et de Soins (PNDS) Syndrome de Marfan et apparent\u00e9s. HAS; 2018. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2018-03\/pnds_syndrome_de_marfan_et_apparente_mars_2018_def.pdf."},{"key":"740_CR25","unstructured":"Centre de R\u00e9f\u00e9rence des Maladies cardiaques h\u00e9r\u00e9ditaires, H\u00f4pital Bichat APHP, Dr Isabelle DENJOY, Centre de r\u00e9f\u00e9rence pour la prise en charge des maladies rythmiques h\u00e9r\u00e9ditaires de, l\u2019Ouest, CHU Nantes, Dr Isabelle DENJOY; Pr Vincent PROBST. Protocole National de Diagnostic et de Soins (PNDS) Syndrome du QT Long. HAS; 2021. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2021-10\/1._protocole_national_de_diagnostic_et_de_soins_syndrome_du_qt_long_cardiogen_isabelle_denjoy.pdf."},{"key":"740_CR26","unstructured":"Centre de r\u00e9f\u00e9rence des Malformations Cardiaques Cong\u00e9nitales Complexes. Protocole National de Diagnostic et de Soins (PNDS) PRISE EN CHARGE DE LA GROSSESSE CHEZ LES PATIENTES AVEC UNE CARDIOPATHIE CONGENITALE COMPLEXE. HAS. Ao\u00fbt 2021. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2021-11\/pnds_ccc_et_grossesse2021texte.pdf."},{"issue":"3","key":"740_CR27","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-0731","volume":"138","author":"BT Bateman","year":"2016","unstructured":"Bateman BT, Patorno E, Desai RJ, et al. Late pregnancy \u03b2 blocker exposure and risks of neonatal hypoglycemia and bradycardia. Pediatrics. 2016;138(3):e20160731. https:\/\/doi.org\/10.1542\/peds.2016-0731.","journal-title":"Pediatrics"},{"issue":"1","key":"740_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/s0301-2115(01)00314-1","volume":"98","author":"J Lind","year":"2001","unstructured":"Lind J, Wallenburg HC. The Marfan syndrome and pregnancy: a retrospective study in a Dutch population. Eur J Obstet Gynecol Reprod Biol. 2001;98(1):28\u201335. https:\/\/doi.org\/10.1016\/s0301-2115(01)00314-1.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"740_CR29","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/s0368-2315(06)76450-x","volume":"35","author":"A Lunel","year":"2006","unstructured":"Lunel A, Audra P, Plauchu H, Gaucherand P. Syndrome de Marfan et grossesse. J Gynecol Obstet Biol Reprod (Paris). 2006;35(6):607\u201313. https:\/\/doi.org\/10.1016\/s0368-2315(06)76450-x.","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"5","key":"740_CR30","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/0002-9378(95)90655-x","volume":"173","author":"JP Rossiter","year":"1995","unstructured":"Rossiter JP, Repke JT, Morales AJ, Murphy EA, Pyeritz RE. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol. 1995;173(5):1599\u2013606. https:\/\/doi.org\/10.1016\/0002-9378(95)90655-x.","journal-title":"Am J Obstet Gynecol"},{"issue":"17","key":"740_CR31","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1136\/heartjnl-2016-310617","volume":"103","author":"K Ishibashi","year":"2017","unstructured":"Ishibashi K, Aiba T, Kamiya C, Miyazaki A, Sakaguchi H, Wada M, et al. Arrhythmia risk and \u03b2-blocker therapy in pregnant women with long QT syndrome. Heart. 2017;103(17):1374\u20139. https:\/\/doi.org\/10.1136\/heartjnl-2016-310617.","journal-title":"Heart"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00740-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-026-00740-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00740-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:13:08Z","timestamp":1773673988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-026-00740-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["740"],"URL":"https:\/\/doi.org\/10.1007\/s40272-026-00740-x","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M\u00e9lissa Gr\u00e9gori, Laurianne Le Gloan, Thomas Goronflot, Jean-Baptiste Gourraud, Emilie Misbert, Norbert Winer, and Vincent Dochez declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Conceptualization: M. Gr\u00e9gori, L. Le Gloan, V. Dochez; Methodology: M. Gr\u00e9gori, T. Goronflot; Data curation: M. Gr\u00e9gori, L. Le Gloan; Formal analysis: T. Goronflot; Investigation: M. Gr\u00e9gori, L. Le Gloan, E. Misbert; Writing\u2014original draft: M. Gr\u00e9gori, V. Dochez; Writing\u2014review and editing: L. Le Gloan, JB Gourraud, E. Misbert, N. Winer; Supervision: J.-B. Gourraud N. Winer.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"The study was approved by the Comit\u00e9 d\u2019Ethique pour la Recherche en Obst\u00e9trique et Gyn\u00e9cologie (CEROG; reference 2023-OBS-0503).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}